| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/04/2003 | US6514690 Immunoreactive antigens of Hepatitis E Virus |
| 02/04/2003 | US6514513 Costimulatory blockade and mixed chimerism in transplantation |
| 02/04/2003 | US6514503 Mucosal administration; glyceride, antigen and vehicle |
| 02/04/2003 | US6514502 Propagation of bovine cononavirus in chinese hamster ovary cells |
| 02/04/2003 | US6514501 Recombinant vaccine against dengue virus |
| 02/04/2003 | US6514499 Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof |
| 02/04/2003 | US6514498 Modified/chimeric superantigens and their use |
| 02/04/2003 | US6514497 Inhibition of LERK-2-mediated cell adhesion |
| 02/04/2003 | US6514496 Dispersible antibody compositions and methods for their preparation and use |
| 02/04/2003 | CA2109815C Antibody preparation |
| 02/04/2003 | CA2063810C Production of vascular endothelial cell growth factor |
| 02/04/2003 | CA2060325C Polypeptides with a dopaminergic receptor activity; nucleic acids coding for these polypeptides and use of the latter for screening active substances on said polypeptides |
| 02/03/2003 | WO2002016548A2 Novel g protein-coupled receptor |
| 02/03/2003 | CA2418130A1 Novel g protein-coupled receptor |
| 01/30/2003 | WO2003008649A1 Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin |
| 01/30/2003 | WO2003008640A2 Asthma-associated gene |
| 01/30/2003 | WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 01/30/2003 | WO2003008574A1 Mutations in ion channels |
| 01/30/2003 | WO2003008571A2 Chimeric chains that code for proteins that induce effects directed against viruses |
| 01/30/2003 | WO2003008558A2 Cd4+cd25+ inhibitory hybridoma clones |
| 01/30/2003 | WO2003008541A2 Extracellular junctional adhesion molecules |
| 01/30/2003 | WO2003008537A2 Epitope sequences |
| 01/30/2003 | WO2003008533A2 Method for virus propagation |
| 01/30/2003 | WO2003008452A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
| 01/30/2003 | WO2003008450A1 Tumor antigen |
| 01/30/2003 | WO2003008449A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | WO2003008448A2 Novel human proton-gated channels |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003007989A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/30/2003 | WO2003007988A1 Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 01/30/2003 | WO2003007987A2 Haptenizing cancer cell components for the preparation of cancer vaccines |
| 01/30/2003 | WO2003007986A2 Vaccine formulation potentiated by the combination of a dna and an antigen |
| 01/30/2003 | WO2003007985A2 Capsular polysaccharide solubilisation and combination vaccines |
| 01/30/2003 | WO2003007971A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | WO2003007889A2 Therapeutic agents comprising pro-apoptotic proteins |
| 01/30/2003 | WO2003007880A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | WO2003007869A2 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 01/30/2003 | WO2002083187A9 Systems and methods for inducing mixed chimerism |
| 01/30/2003 | WO2002079478A3 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders |
| 01/30/2003 | WO2002048180A3 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 01/30/2003 | WO2002034918A3 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 01/30/2003 | WO2002034772A3 Novel compounds |
| 01/30/2003 | WO2002018583A3 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/30/2003 | WO2002010393A3 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 01/30/2003 | WO2002004599A3 Placental protein having multiple egf-like domains |
| 01/30/2003 | WO2001091792A9 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network |
| 01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 01/30/2003 | WO2001068853A3 Immunogenic ovarian cancer genes |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |
| 01/30/2003 | WO2001025273A9 Compositions and methods for wt1 specific immunotherapy |
| 01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
| 01/30/2003 | US20030023066 For therapy and prophylaxis of Helicobacter infection |
| 01/30/2003 | US20030023061 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 01/30/2003 | US20030023056 In immunogenic preparations or diagnostic applications |
| 01/30/2003 | US20030023047 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer |
| 01/30/2003 | US20030023045 Reshaped human antibody to human medulloblastoma cells |
| 01/30/2003 | US20030023038 For therapy of undesired cell proliferation; for stimulation and inhibition of lymphocytes |
| 01/30/2003 | US20030023036 Drugs, vaccines |
| 01/30/2003 | US20030023034 p27 (Kip1) -FKBP-12 protein complexes |
| 01/30/2003 | US20030023033 Novel class II cytokine receptors and uses thereof |
| 01/30/2003 | US20030023032 LuxO-sigma54 interactions and methods of use |
| 01/30/2003 | US20030022918 (imidazoly-5-yl)methyl-2-quinolinone derivatives; antitumor agents |
| 01/30/2003 | US20030022860 CD40 binding molecules and CTL peptides for treating tumors |
| 01/30/2003 | US20030022854 Vaccines using nucleic acid-lipid complexes |
| 01/30/2003 | US20030022852 Biodegradable immunomodulatory formulations and methods for use thereof |
| 01/30/2003 | US20030022849 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/30/2003 | US20030022835 Compositions isolated from skin cells and methods for their use |
| 01/30/2003 | US20030022826 Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes of autoantigens or infectious agents |
| 01/30/2003 | US20030022820 Peptides useful in activating tumor-specific cytotoxic T cells in vivo with specificity for particular antigenic peptides |
| 01/30/2003 | US20030022813 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 01/30/2003 | US20030022812 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 01/30/2003 | US20030022378 Expression vector for use as transfer tool in genetic engineering |
| 01/30/2003 | US20030022359 Transgenic algae for delivering antigens to an animal |
| 01/30/2003 | US20030022338 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 01/30/2003 | US20030022333 Preservation of samples by dehydration; obtain sample, dry, cool and store on shell |
| 01/30/2003 | US20030022325 Nucleotide sequences coding transport protein for use in diagnosis and treatment of cancers, kidney, bone and nervous sysem disorders |
| 01/30/2003 | US20030022312 Human hepatoma-derived growth factor-2 |
| 01/30/2003 | US20030022308 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 01/30/2003 | US20030022304 Reduce interference associated with hemophilis vaccine; obtain sample, incubate with aluminium hydroxide adjuvant, expose to antigens, recover vaccine |
| 01/30/2003 | US20030022302 Toll-like receptor |
| 01/30/2003 | US20030022284 Polypeptide for use in the diagnosis and treatment of kidney defects |
| 01/30/2003 | US20030022272 Method of inducing an antigen-specific anticytotoxic cell |
| 01/30/2003 | US20030022238 Methods of identifying agents which inhibit GPR-9-6 |
| 01/30/2003 | US20030022211 Nucleotide sequences coding polypeptide for use in diagnosis and prevention of psychological and nervous system disorders |
| 01/30/2003 | US20030022209 ADSLs as modifiers of the p53 pathway and methods of use |
| 01/30/2003 | US20030022188 Compositions and methods relating to colon specific genes and proteins |
| 01/30/2003 | US20030022181 Streptococcus pneumoniae antigens |
| 01/30/2003 | US20030022178 Identification of sortase gene |
| 01/30/2003 | US20030022158 Peptide for use in the treatment of viral infection |
| 01/30/2003 | US20030021838 Anticancer agents; vaccines; induction immunology response |
| 01/30/2003 | US20030021812 Genetic engineering; vaccines; induction immunology response, antibodies |
| 01/30/2003 | US20030021811 Modulating production of pneumococcal capsular polysaccharide |
| 01/30/2003 | US20030021809 Nucleic acid expression vector |
| 01/30/2003 | US20030021808 Cd40 ligand adjuvant for respiratory syncytial virus |
| 01/30/2003 | US20030021807 Prevent lentivirus infections; polypeptides |
| 01/30/2003 | US20030021806 Papilloma virus capsomere vaccine formulations and method of use |
| 01/30/2003 | US20030021805 Generation of HCV-like particles and chimeric HCV virus |
| 01/30/2003 | US20030021804 Immunological process for increasing the hdl cholestrol concentration |
| 01/30/2003 | US20030021803 Transgenic plant-based vaccines |